Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Top Cited Papers
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 133 (2), 412-422
- https://doi.org/10.1053/j.gastro.2007.05.051
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II TrialAmerican Journal of Gastroenterology, 2005
- A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on AzathioprineGastroenterology, 2005
- Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s diseaseGastroenterology, 2005
- Mucosal Healing in Pediatric Crohnʼs DiseaseInflammatory Bowel Diseases, 2004
- Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitisBMC Gastroenterology, 2004
- Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s diseaseGastroenterology, 2004
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Incidence of Inflammatory Bowel Disease in Southeastern Norway: Evaluation of Methods after 1 Year of RegistrationDigestion, 1995
- Classification of Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1989